Shakir S - Search Results

1

Challenges for Drug Repurposing in the COVID-19 Pandemic Era.

Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifirò G. Sultana J, et al. Among authors: shakir s. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Front Pharmacol. 2020. PMID: 33240091 Free PMC article. Review.

2

New postgraduate qualifications in pharmacovigilance from the Drug Safety Research Unit in the UK.

Lynn E, Layton D, Shakir S. Lynn E, et al. Among authors: shakir s. Drug Saf. 2011 Jan 1;34(1):89-91. doi: 10.2165/11586810-000000000-00000. Drug Saf. 2011. PMID: 21142274

3

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England.

McNaughton R, Lynn E, Osborne V, Coughtrie A, Layton D, Shakir S. McNaughton R, et al. Among authors: shakir s. Drug Saf. 2016 Apr;39(4):323-33. doi: 10.1007/s40264-015-0384-7. Drug Saf. 2016. PMID: 26798051 Free PMC article.

4

Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.

Lane S, Lynn E, Shakir S. Lane S, et al. Among authors: shakir s. BMJ Open. 2018 Jan 23;8(1):e019759. doi: 10.1136/bmjopen-2017-019759. BMJ Open. 2018. PMID: 29362275 Free PMC article.

5

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

Dhanda S, Osborne V, Lynn E, Shakir S. Dhanda S, et al. Among authors: shakir s. BMJ Evid Based Med. 2022 Feb;27(1):1-6. doi: 10.1136/bmjebm-2020-111507. Epub 2020 Oct 21. BMJ Evid Based Med. 2022. PMID: 33087452 Free PMC article.

6

A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events.

Dhanda S, Evans A, Roy D, Osborne V, Townsley A, Coutinho G, Kulasekaran A, Shakir S. Dhanda S, et al. Among authors: shakir s. Front Pharmacol. 2021 Aug 4;12:726141. doi: 10.3389/fphar.2021.726141. eCollection 2021. Front Pharmacol. 2021. PMID: 34421619 Free PMC article.

7

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.

Raethke M, van Hunsel F, Thurin NH, Dureau-Pournin C, Mentzer D, Kovačić B, Mirošević Skvrce N, De Clercq E, Sabbe M, Trifirò G, Luxi N, Giovanazzi A, Shakir S, Klungel OH, Schmikli S, Sturkenboom M. Raethke M, et al. Among authors: shakir s. Drug Saf. 2023 Apr;46(4):391-404. doi: 10.1007/s40264-023-01281-9. Epub 2023 Apr 7. Drug Saf. 2023. PMID: 37024736 Free PMC article.

8

Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project.

Hazell L, Raschi E, De Ponti F, Thomas SH, Salvo F, Ahlberg Helgee E, Boyer S, Sturkenboom M, Shakir S. Hazell L, et al. Among authors: shakir s. J Clin Pharmacol. 2017 May;57(5):558-572. doi: 10.1002/jcph.838. Epub 2016 Dec 26. J Clin Pharmacol. 2017. PMID: 28019033 Review.

9

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.

Davies M, Osborne V, Lane S, Roy D, Dhanda S, Evans A, Shakir S. Davies M, et al. Among authors: shakir s. Drug Saf. 2020 Jul;43(7):645-656. doi: 10.1007/s40264-020-00952-1. Drug Saf. 2020. PMID: 32468196 Free PMC article.

10

Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997.

Craig-McFeely PM, Acharya NV, Shakir SA. Craig-McFeely PM, et al. Among authors: shakir sa. Eur J Clin Pharmacol. 2001 Jul;57(4):313-20. doi: 10.1007/s002280100292. Eur J Clin Pharmacol. 2001. PMID: 11549210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page